Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) shares rose 3% on Monday . The stock traded as high as $0.8911 and last traded at $0.8911. Approximately 200 shares traded hands during trading, an increase of 2,122% from the average daily volume of 9 shares. The stock had previously closed at $0.8654.
Sino Biopharmaceutical Stock Up 3.0%
The stock has a fifty day simple moving average of $0.87 and a two-hundred day simple moving average of $0.92.
Sino Biopharmaceutical Company Profile
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Read More
- Five stocks we like better than Sino Biopharmaceutical
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Trump’s Hand-Written Letter Will Shock his Haters
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
